Medtronic (MDT)
(Delayed Data from NYSE)
$79.74 USD
+0.49 (0.62%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $79.98 +0.24 (0.30%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDT 79.74 +0.49(0.62%)
Will MDT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MDT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDT
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
Medtronic (MDT) Laps the Stock Market: Here's Why
MDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Medtronic (MDT) Stock for Now
The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Other News for MDT
Medtronic gets FDA okay for Inceptiv closed-loop spinal cord stimulator
June 7th Options Now Available For Medtronic
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic announces approval of Inceptiv closed-loop rechargeable SCS by FDA
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys